Fund Gurus

Immunogen: A Game Changing Stock With Tremendous Upside Potential

ImmunoGen Inc

ImmunoGen Inc (NASDAQ:IMGN) is a small-cap biotech stock. Biotech stocks can be particularly hard to analyze, often having negative earnings and historically posting losses, before eventually becoming profitable businesses. Success and also failures often hinge on one key drug or product. Therefore understanding the drug(s) the company is developing, or have developed, and determining the likelihood of it being brought to market is key. Forecasting revenues such a product/drug could generate as well as assessing future pipeline products helps provide an overall valuation and growth forecast. The following analysis indentifies the game changing nature of IMG's biotechnology in the ongoing battle against cancer and shows with conservative forecasts that IMGN offers significant capital upside.



Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details